sFlt-1/PlGF Ratio as a Predictive Marker in Women with Suspected Preeclampsia: An Economic Evaluation from a Swiss Perspective

<div>Patient management diagram for the no-testing strategy (based on standard of care) and assumed hospitalization rates according to the PROGNOSIS study. Grey shading indicates confirmed cases of preeclampsia. PlGF: placental growth factor; sFlt-1: soluble fms-like tyrosine kinase-1; SOC: standard of care.</div>

Disease Markers

fig1

Figure 1

Figure 1: sFlt-1/PlGF Ratio as a Predictive Marker in Women with Suspected Preeclampsia: An Economic Evaluation from a Swiss Perspective 